Safety of difelikefalin for itching in teens on dialysis
Part of Kidney & urinary, Skin, Women’s health & pregnancy clinical trials.
This trial tests a drug called difelikefalin to see if it safely reduces moderate-to-severe itching in teenagers who are on hemodialysis. Itching is common in kidney disease, and this study aims to find a new treatment option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 12 and 17 years old
- You have been on hemodialysis 3 times a week for at least 12 weeks
- You have had moderate-to-severe itching for at least 4 days in the past week
- You weigh at least 44 pounds (20 kg)
- Your itching is not caused by other skin conditions like eczema or hives
- You are not planning to get a kidney transplant during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether dupilumab injections can reduce severe itching that has no clear cause. It also checks how safe the medicine is over the study period.
This study looks at itching caused by drug-induced liver injury. Researchers want to understand who gets itchy and how bad it is, which could help improve care for people with this condition.
This trial tests a new device called WEAKID for people on peritoneal dialysis. It aims to see if the device is safe to use. Participants must have been on PD for at least 3 months and have no recent infections or catheter problems.
This trial tests a medication called difelikefalin to relieve severe itching in people on long-term kidney dialysis. Many dialysis patients experience persistent itching that affects their quality of life, and this study explores whether this drug can help.
This trial tests a new tablet called nalfurafine to help reduce severe itching that happens in people on regular kidney dialysis. If you've had itching for a while despite trying other treatments, this study may help you and contribute to better options for dialysis patients.
This trial tests if a medication called nalfurafine hydrochloride (taken as a tablet that melts in your mouth) can help reduce moderate to severe itching in people receiving peritoneal dialysis for chronic kidney disease.
Hear when a new Pruritus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.